Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Jonathan, Kil"'
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 14 (2021)
Aminoglycosides (AG) antibiotics are a common treatment for recurrent infections in cystic fibrosis (CF) patients. AGs are highly ototoxic, resulting in a range of auditory dysfunctions. It was recently shown that the acoustic startle reflex (ASR) ca
Externí odkaz:
https://doaj.org/article/f3abf2117e274f3391e4e8c284aad1a1
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
Aminoglycosides (AG) such as amikacin are commonly used in cystic fibrosis patients with opportunistic pulmonary infections including multi-drug resistant mycobacterium tuberculous and non-tuberculous mycobacterium. Unfortunately, this class of drugs
Externí odkaz:
https://doaj.org/article/4670d2050113403ab8d8e2a88795f8c2
Publikováno v:
Journal of Cystic Fibrosis. 20:271-277
Background Cystic fibrosis patients are often adminstered tobramycin to treat pulmonary infections. Unfortunately, a common side effect is hearing loss, which can fluctuate. Ebselen has known anti-inflammatory properties and could reduce the incidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697f9fa7d6455ee470795f5b7b69fbe7
https://doi.org/10.1016/j.jcf.2020.02.014
https://doi.org/10.1016/j.jcf.2020.02.014
Autor:
Daniel Dorgan, E. Emily Harruff, Angela G. Shoup, Robert C. Fifer, Raksha Jain, Jonathan Kil, Patrick A. Flume, Maria Gabriela Tupayachi Ortiz, Elizabeth A. Poth, Yun Jin M. Kim
Publikováno v:
Journal of Cystic Fibrosis. 20:288-294
Aminoglycosides are commonly used to treat infections in CF patients and are highly ototoxic. The incidence of tobramycin-induced hearing loss, tinnitus, vertigo or dizziness (ototoxicity) varies widely from 0 to 56% secondary to variation in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac0994fa8693cee25d784e3180442051
https://doi.org/10.1016/j.jcf.2020.11.020
https://doi.org/10.1016/j.jcf.2020.11.020
Autor:
Sina Koochakzadeh, Shaun A. Nguyen, Paul R. Lambert, Prashant N. Bhenswala, Theodore R. McRackan, Jonathan Kil, Avigeet Gupta
Publikováno v:
Otology & Neurotology. 41:e971-e981
OBJECTIVE To determine the efficacy of various treatment modalities used for acute noise-induced hearing loss (aNIHL) from acute acoustic trauma (AAT) via a systematic review and meta-analysis. DATA SOURCES PubMed, Cochrane, and Scopus databases. STU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaea1ca0efb96e5d312adf3f1351af6c
https://doi.org/10.1097/mao.0000000000002760
https://doi.org/10.1097/mao.0000000000002760
Publikováno v:
Frontiers in Molecular Neuroscience
Frontiers in Molecular Neuroscience, Vol 14 (2021)
Frontiers in Molecular Neuroscience, Vol 14 (2021)
Aminoglycosides (AG) antibiotics are a common treatment for recurrent infections in cystic fibrosis (CF) patients. AGs are highly ototoxic, resulting in a range of auditory dysfunctions. It was recently shown that the acoustic startle reflex (ASR) ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a93960f22dcf7d15b8d8d9781edc0b38
http://europepmc.org/articles/PMC8440845
http://europepmc.org/articles/PMC8440845
Publikováno v:
Frontiers in Neuroscience
Frontiers in Neuroscience, Vol 14 (2020)
Frontiers in Neuroscience, Vol 14 (2020)
Aminoglycosides (AG) such as amikacin are commonly used in cystic fibrosis patients with opportunistic pulmonary infections including multi-drug resistant mycobacterium tuberculous and non-tuberculous mycobacterium. Unfortunately, this class of drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6883c669cd0bc7934e1cc6770a7585c9
https://doi.org/10.3389/fnins.2020.561185
https://doi.org/10.3389/fnins.2020.561185
Autor:
E Emily, Harruff, Jonathan, Kil, Maria Gabriela Tupayachi, Ortiz, Daniel, Dorgan, Raksha, Jain, Elizabeth A, Poth, Robert C, Fifer, Yun Jin M, Kim, Angela G, Shoup, Patrick A, Flume
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 20(2)
Aminoglycosides are commonly used to treat infections in CF patients and are highly ototoxic. The incidence of tobramycin-induced hearing loss, tinnitus, vertigo or dizziness (ototoxicity) varies widely from 0 to 56% secondary to variation in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e757e2c4329e516a6bd57e76e145b55e
https://pubmed.ncbi.nlm.nih.gov/33341407
https://pubmed.ncbi.nlm.nih.gov/33341407
Publikováno v:
Hearing Research. 413:108209
The global impact of hearing loss and related auditory dysfunction including tinnitus and hyperacusis on human health is significant and growing. A substantial body of literature has found that these hearing diseases and disorders result from signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1e5dbe719fba225dc29d3d684a912b7
https://doi.org/10.1016/j.heares.2021.108209
https://doi.org/10.1016/j.heares.2021.108209
Autor:
Jonathan Kil, Patrick J. Antonelli, Scott K. Griffiths, Edward Lobarinas, Christopher Spankovich, Colleen G. Le Prell, Eric D. Lynch
Publikováno v:
The Lancet. 390:969-979
Summary Background Noise-induced hearing loss is a leading cause of occupational and recreational injury and disease, and a major determinant of age-related hearing loss. No therapeutic agent has been approved for the prevention or treatment of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a0379ac9fc614d9733f6b9636cdac3
https://doi.org/10.1016/s0140-6736(17)31791-9
https://doi.org/10.1016/s0140-6736(17)31791-9